ERK1/2在糖尿病心肌病发展中作用机制的研究进展
2017-05-30易偲李俊明
易偲 李俊明
【摘要】糖尿病心肌病(DCM)是一种在糖尿病状态下出现的心肌病变,即在微血管病变的基础上出现心肌广泛灶性坏死,并导致亚临床的心功能异常,最终进展为心律失常、心力衰竭及心源性休克等,重症患者甚至可出现猝死。DCM的发展与丝裂原活化蛋白激酶(也被称为胞外调节激酶,ERK)之间的相关性一直是学者们研究的热点。目前已知ERK1/2参与调节心肌肥厚和心功能障碍,并可以预防缺血/再灌注和心肌梗死对DCM造成损伤。该文针对ERK1/2在DCM发展中的作用机制进行了论述,主要包括ERK1/2在氧化应激、细胞凋亡、心肌肥厚、心肌纤维化等过程中所起的作用。
【关键词】糖尿病心肌病;胞外调节激酶1/2;心脏功能障碍;心脏重塑
Research progress on the role of ERK1/2 in the development of diabetic cardiomyopathyYi Cai,Li JunmingDepartment of Cardiology, Renmin Hospital of Three Gorges University(the First Peoples Hospital of Yichang),Yichang 443000, China
Corresponding author, Li Junming, Email:lijunming@medmailcomcn
【Abstract】Diabetic cardiomyopathy (DCM) is a type of cardiomyopathy that occurs in the state of diabetes mellitus, which causes extensive myocardial necrosis on the basis of microvascular disease and leads to subclinical cardiac dysfunction that eventually progress into arrhythmia, heart failure, cardiogenic shock and even sudden death The relationship between the development of DCM and mitogenactivated protein kinase (extracellular signal kinase,ERK) has been a hot topic for scholars ERK1/2 has been known to regulate cardiac hypertrophy and cardiac dysfunction and prevent the cardiac injury induced by ischemia/reperfusion and myocardial infarction in DCM patients In this article, the role of ERK1/2 in the development of DCM was reviewed, which was mainly involved with the role of ERK1/2 in oxidative stress, cellular apoptosis, cardiac hypertrophy and cardiac fibrosis, etc
【Key words】Diabetic cardiomyopathy; Extracellular signal kinase 1/2;
Cardiac dysfunction; Cardiac remodeling
糖尿病是目前最常見的代谢性疾病,2010年中国国家疾病预防控制中心对中国 18 周岁以上人群糖尿病的患病情况进行了调查,若应用WHO 1999年的诊断标准,我国糖尿病的患病率为 97%,若同时以GHbA1c≥65%作为诊断标准,则患病率高达 116%,遂证实我国目前已成为世界上糖尿病患病人数最多的国家[1]。1972年,Rubler首次提出了糖尿病心肌病(DCM)的概念,其是一种特异性心肌病,发病机制较为复杂,至今仍未完全阐明,所以目前诊断上主要采用排他性诊断的方法,治疗上也存在一定困难[24]。最近有研究表明,丝裂原活化蛋白激酶(MAPK),也被称为胞外调节激酶(ERK),其家族成员之一的ERK1/2在调节心肌细胞氧化应激、细胞凋亡、心肌肥厚、心肌纤维化等过程中均发挥了作用,研究显示这些过程均与DCM有关[5]。……
